Innovation Details

Intellectual Property Summary

We have filed our provisional patent applications for methods and algorithms, and plan to file design patents.

Clinical Information

At Helpsy, we have performed a series of research studies to demonstrate the effectiveness of our software and symptom management approach on real cancer survivors.

Our two studies, a three-year clinical study performed in conjunction with UCSF and the NIH and a two-month study performed in conjunction with the EMC Super Specialty Hospital in Amritsar, India, have shown significant improvements in quality of life and chronic symptoms with increased patient engagement.

UCSF Study:Qualitative Analyses from a Prospective Clinical Study of a Whole Sys. Ayurvedic Intervention for Breast Cancer Survivorship, Lapedis et al., J Altern Complement Med, 2014. Link: http://online.liebertpub.com/doi/abs/10.1089/acm.2014.5196.abstract
EMC Study:Manuscript in progress.

Regulatory Status

My project does not require FDA compliance. My project is HIPAA-compliant.

How we will use the funds raised

With an investment, we can increase our marketing and sales effort through the funding of more conference appearances and sales trips, we can purchase additional HIPAA-compliant servers and other software as we gain accounts, and we can ramp up our engineering effort for development and maintenance of our software.

Thank You

As an oncology nurse, I saw my brave patients endure so many physical, emotional, financial, and social scars during their fight against cancer. These scars continue to haunt them and impact many aspects of their lives. At Helpsy, we map out the cancer journey and prepare cancer patients for the challenges ahead. We provide access to the best treatments and best providers from all reliable health care fields. We save clinicians time and money by automating this care planning process so that clinicians can focus their time on what is most important, caring for patients. Join us in providing better care to cancer patients and better tools to cancer clinicians!

Investor Info

Market Size

The cancer symptom management market is a $2 billion market, while the chronic out-of-pocket symptom management market is an almost $12 billion market. Helpsy is currently in talks with UCSF and Sutter Health, so we have positioned ourselves to gain approval from major hospitals and tap into this cancer market. Opportunities for further expansion are just as abundant as hospitals and cancer care centers are!

Projected 3 Year Growth

Our total target market in $12billion in symptom managment with $2b in cancer symptom management. For cancer symptom managment, we expect our revenue to be approximately $60m-$100m in three years with a gross margin of 50-60%. In addition, we are already in the process of developing and deploying a solution for non-pharma options for pain management with Health and human services department and other govt. and private agencies (to address opioid crisis). 

Revenue Model

We generate revenue from referrals, from cancer centers, and from Pharmaceutical companies.

From referrals, we will take 15% of the initial consultation fee and 5% of the consultation fee from ongoing consultation with the patient.

While we provide our basic care plan to cancer centers for free, we charge for higher tier models where we offer more survivorship care on behalf of the hospital. In addition, we charge for value-add services such as compliance reports, analytics reports and reminders for diagnostics, as well as nursing education and our enterprise-level survivorship care plan.

Pharmaceutical companies with non-generic treatments and drugs are willing to pay a high price to advertise to clinicians at the point of care and to patients. In addition, currently, the lifetime dose of a drug is not met because patients discontinue in between. Also, there are wars to capture market for same drug type from various companies - the symptom management profile is the deciding factor in which drug is most acceptable . By supporting their side effects and tracking drug use, we help pharma companies achieve maximum value they can generate from a patient. In addition, pharma companies are interested in long term patient data. Several pharma companies are very interested in opportunity with us and we are in ongoing discussion with them.

Competitors

Our primary competitors are NurseNavigator (http://nursenavigation.com/) and SurvivorPlan (http://survivorplan.io/). Both of these lag our solution because of their limitations: neither product is fully digital, neither has HIPAA compliance, and neither has EMR integration. We also differentiate ourselves through our patented algorithms. In addition, neither was designed by an oncology nurse--neither was designed to address the needs of clinicians and patients.

Traction

We are launching pilots with 2 major hospitals and are already rolled out in smaller community cancer centers. We are in conversation with several major pharma companies who are interested in very lucrative partnership for advertising and symptom management once we finish these pilots and reach a certain number of clinicians and patients on our platform. We are partnering with about 1 major cancer center per quarter. In addition, on our consumer app, we are getting about a 10% increase in new users every month.

Due Diligence Docs

Please note that access to the company's confidential materials is limited. Click this button to request access from the Company and its representatives.

Send access request

Supporters

• 
  Alex Fair, MS
  02/12/2018 - Liked the project.
• 
  Ms. Sangeeta Agarawal, RN, MS
  10/23/2017 - Backed the project for $100

Comments

Updates

No updates found .